Joseph P. Lucia & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-75
Closed -$18K 433
2022
Q1
$18K Buy
+75
New +$17.2K 0.01% 274
2021
Q4
Sell
-75
Closed -$16K 139
2021
Q3
$16K Hold
75
0.01% 329
2021
Q2
$18K Hold
75
0.01% 325
2021
Q1
$19K Hold
75
0.01% 296
2020
Q4
$17K Buy
+75
New +$17.3K 0.01% 284
2020
Q3
Sell
-75
Closed -$18K 101
2020
Q2
$18K Hold
75
0.02% 249
2020
Q1
$15K Hold
75
0.02% 248
2019
Q4
$18K Hold
75
0.02% 253
2019
Q3
$15K Hold
75
0.02% 271
2019
Q2
$14K Sell
75
-14,541
-99% -$2.6M 0.01% 270
2019
Q1
$75 Buy
+14,616
New +$2.79M 0.01% 277

Other funds holding AMGN

Joseph P. Lucia & Associates's AMGN Position: Q2 2022 in Review

Joseph P. Lucia & Associates sold out of Amgen (AMGN) in Q2 2022, closing a stake of 75 shares — an estimated $18K sold.

Joseph P. Lucia & Associates first reported a position in AMGN in Q1 2019 and held it in 11 quarters. The position peaked at $19K in Q1 2021. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Joseph P. Lucia & Associates reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 75 Amgen shares in Q2 2022, an estimated $18K.
  • Joseph P. Lucia & Associates first reported a position in Amgen in Q1 2019 and held it in 11 quarters.
  • Joseph P. Lucia & Associates's Amgen position peaked at $19K in Q1 2021.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q2 2022, filed 26 Jul 2022.